Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty

NCT03234374 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hernioplasty

Interventions

COMBINATION_PRODUCT: INL-001 (bupivacaine HCl collagen implant)
DRUG: Marcaine 0.25% infiltration

Sponsor

Innocoll

Collaborators

[object Object]